Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Immune Thrombocytopenia (ITP) and Hβ-1 Tubulin: The Arg307His Substiution Is Over-Represented and Identifies Patients with More Severe Disease

Paul Andrew Basciano, MD, Luis Javier Leandro-Garcia, PhD, Cristina Rodriguez-Antona, PhD, Paraskevi Giannakakou, PhD, James B. Bussel, MD

Blood (2010) 116 (21): 2525.

https://doi.org/10.1182/blood.V116.21.2525.2525

Published: 2010

Journal Articles

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay R. Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Ed Copelan, MD, Lukasz P. Gondek, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS

Blood (2008) 112 (11): 921.

https://doi.org/10.1182/blood.V112.11.921.921

Published: 2008

Journal Articles

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Jaroslaw P. Maciejewski, MD, PhD, Edward Copelan, MD, Mikkael A. Sekeres, MD

Blood (2007) 110 (11): 4292.

https://doi.org/10.1182/blood.V110.11.4292.4292

Published: 2007

Journal Articles

Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas

Cristina Rodríguez-Antona, Susanna Leskelä, Magdalena Zajac, Marta Cuadros, Javier Alvés, Maria Victoria Moneo, Carmen Martín, Juan Cruz Cigudosa, Amancio Carnero, Mercedes Robledo, Javier Benitez, Beatriz Martínez-Delgado

Blood (2007) 110 (9): 3345–3351.

https://doi.org/10.1182/blood-2007-02-075036

Published: 2007

Includes: Supplemental data

Journal Articles

Impact of Socioeconomic Status and Distance from Treatment Center on Survival in Patients Receiving Remission Induction Therapy for Newly Diagnosed Acute Myelogenous Leukemia (AML).

Cristina Rodriguez, Rachid Baz, Rony Abou Jawde, Lisa Rybicki, Christopher Lowe, Matt Kalaycio, Anjali Advani, Ronald Sobecks, Mikkael A. Sekeres

Blood (2006) 108 (11): 1920.

https://doi.org/10.1182/blood.V108.11.1920.1920

Published: 2006

Journal Articles

Prognostic Factors and Outcomes of Patients with Acute Myeloid Leukemia (AML) Receiving Non Intensive Chemotherapy (NIC) or Best Supportive Care (BSC).

Rachid Baz, Cristina Rodriguez, Rony Abou Jawde, Lisa Rybicki, Matt Kalaycio, Anjali Advani, Ronald Sobecks, Mikkael A. Sekeres

Blood (2006) 108 (11): 4492.

https://doi.org/10.1182/blood.V108.11.4492.4492

Published: 2006

Journal Articles

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Cristina Rodriguez, MD, Tao Jin, MS, Rony Abou Jawde, MD, Wael Saber, MD, Rachid Baz, MD, Eric His, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Anjali Advani, MD

Blood (2006) 108 (11): 4510.

https://doi.org/10.1182/blood.V108.11.4510.4510

Published: 2006

NARROW

Immune Thrombocytopenia (ITP) and Hβ-1 Tubulin: The Arg307His Substiution Is Over-Represented and Identifies Patients with More Severe Disease

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas

Impact of Socioeconomic Status and Distance from Treatment Center on Survival in Patients Receiving Remission Induction Therapy for Newly Diagnosed Acute Myelogenous Leukemia (AML).

Prognostic Factors and Outcomes of Patients with Acute Myeloid Leukemia (AML) Receiving Non Intensive Chemotherapy (NIC) or Best Supportive Care (BSC).

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Email alerts

ASH Publications

American Society of Hematology

Immune Thrombocytopenia (ITP) and Hβ-1 Tubulin: The Arg307His Substiution Is Over-Represented and Identifies Patients with More Severe Disease

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas

Impact of Socioeconomic Status and Distance from Treatment Center on Survival in Patients Receiving Remission Induction Therapy for Newly Diagnosed Acute Myelogenous Leukemia (AML).

Prognostic Factors and Outcomes of Patients with Acute Myeloid Leukemia (AML) Receiving Non Intensive Chemotherapy (NIC) or Best Supportive Care (BSC).

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only